Loading…
Suraksha Diagnostic (SURAKSHA)₹350.40+1.96%Healthcare Service Provider
At the end of the Jun 2026 quarter, Suraksha Diagnostic's shareholders were: promoters 49.14%, FIIs 13.44%, DIIs 23.23%, public 14.19%. Promoter holding is unchanged on the quarter. FII holding is down 0.48 percentage points from 13.92% a year earlier. It had 64,873 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 48.82% | 48.82% | 48.93% | 49.02% | 49.04% | 49.14% | 49.14% |
| FIIs | 15.36% | 14.43% | 13.92% | 13.70% | 13.43% | 13.43% | 13.44% |
| DIIs | 20.44% | 22.06% | 22.38% | 21.99% | 22.58% | 23.15% | 23.23% |
| Public | 15.38% | 14.69% | 14.77% | 15.29% | 14.95% | 14.28% | 14.19% |
| Number of shareholders | 98,672 | 87,284 | 79,678 | 75,312 | 70,970 | 67,114 | 64,873 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ritu Mittal | Promoter | 15.91% | 0.00 |
| Orbimed Asia Ii Mauritius Limited | FII | 12.87% | 0.00 |
| Satish Kumar Verma | Promoter | 10.80% | 0.00 |
| Sarla Kejriwal | Promoter | 9.22% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Pha | DII | 7.44% | 0.00 |
| Kotak Small Cap Fund | DII | 6.45% | +0.32 |
| Somnath Chatterjee | Promoter | 5.11% | 0.00 |
| Tinni Investments Limited | Promoter | 4.63% | 0.00 |
| Aditya Birla Sun Life Trustee Private Limited A/C | DII | 3.82% | 0.00 |
| Dneema Overseas Private Limited | Promoter | 3.22% | 0.00 |
| Carnelian Bharat Amritkaal Fund | DII | 2.36% | 0.00 |
| Bandhan Balanced Advantage Fund | DII | 1.33% | 0.00 |
| Aparajita Chatterjee | Promoter | 0.10% | 0.00 |
| Bipul Mittal | Promoter | 0.04% | 0.00 |
| Bipul Mittal HUF | Promoter | 0.03% | 0.00 |
| Jm Financial Mutual Fund-Jm Value Fund | DII | Exited | — |
| Gopal Krishna Mittal HUF | Promoter | 0.00% | 0.00 |
Promoters held 49.14% of Suraksha Diagnostic at the end of the Jun 2026 quarter, up 0.21 percentage points from 48.93% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 13.44% (up 0.01 percentage points from 13.43% a quarter earlier) and domestic institutions (DIIs) held 23.23% (up 0.08 percentage points from 23.15% a quarter earlier).
Suraksha Diagnostic had 64,873 shareholders at the end of the Jun 2026 quarter, against 79,678 a year earlier.
Orbimed Asia Ii Mauritius Limited (FII) held 12.87% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.